# PRevEnting FracturEs in REnal Disease - 1

> **NCT05096195** · PHASE4 · ACTIVE_NOT_RECRUITING · sponsor: **Western University, Canada** · enrollment: 60 (estimated)

## Conditions studied

- Kidney Diseases
- Dialysis; Complications
- Fragility Fracture
- Chronic Kidney Disease-Mineral and Bone Disorder

## Interventions

- **DRUG:** Denosumab 60 mg/ml
- **OTHER:** Calcium and vitamin D prophylaxis
- **DIAGNOSTIC_TEST:** Monitoring of post-injection calcium and phosphate

## Key facts

- **NCT ID:** NCT05096195
- **Lead sponsor:** Western University, Canada
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-06-11
- **Primary completion:** 2025-12
- **Final completion:** 2025-12
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2025-05-31

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05096195

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05096195, "PRevEnting FracturEs in REnal Disease - 1". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05096195. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*